nodes	percent_of_prediction	percent_of_DWPC	metapath
Procarbazine—Footdrop—Thalidomide—leprosy	0.1	0.1	CcSEcCtD
Procarbazine—Peroneal nerve palsy—Thalidomide—leprosy	0.0854	0.0854	CcSEcCtD
Procarbazine—Acute myeloid leukaemia—Thalidomide—leprosy	0.0704	0.0704	CcSEcCtD
Procarbazine—Menopause—Thalidomide—leprosy	0.0509	0.0509	CcSEcCtD
Procarbazine—Acute leukaemia—Thalidomide—leprosy	0.0405	0.0405	CcSEcCtD
Procarbazine—Pericarditis—Thalidomide—leprosy	0.0267	0.0267	CcSEcCtD
Procarbazine—Ascites—Thalidomide—leprosy	0.0254	0.0254	CcSEcCtD
Procarbazine—Hyporeflexia—Thalidomide—leprosy	0.0254	0.0254	CcSEcCtD
Procarbazine—Febrile neutropenia—Thalidomide—leprosy	0.0192	0.0192	CcSEcCtD
Procarbazine—Thrombosis—Thalidomide—leprosy	0.0163	0.0163	CcSEcCtD
Procarbazine—Nystagmus—Thalidomide—leprosy	0.0162	0.0162	CcSEcCtD
Procarbazine—Pleural effusion—Thalidomide—leprosy	0.0151	0.0151	CcSEcCtD
Procarbazine—Petechiae—Thalidomide—leprosy	0.0141	0.0141	CcSEcCtD
Procarbazine—Pancreatitis—Dapsone—leprosy	0.0139	0.0139	CcSEcCtD
Procarbazine—Amenorrhoea—Thalidomide—leprosy	0.0132	0.0132	CcSEcCtD
Procarbazine—Photosensitivity reaction—Dapsone—leprosy	0.0129	0.0129	CcSEcCtD
Procarbazine—Neuropathy peripheral—Dapsone—leprosy	0.0124	0.0124	CcSEcCtD
Procarbazine—Hearing impaired—Thalidomide—leprosy	0.0121	0.0121	CcSEcCtD
Procarbazine—Neuropathy—Thalidomide—leprosy	0.0109	0.0109	CcSEcCtD
Procarbazine—Gynaecomastia—Thalidomide—leprosy	0.0103	0.0103	CcSEcCtD
Procarbazine—Photosensitivity—Thalidomide—leprosy	0.00956	0.00956	CcSEcCtD
Procarbazine—Deafness—Thalidomide—leprosy	0.00938	0.00938	CcSEcCtD
Procarbazine—Vascular purpura—Thalidomide—leprosy	0.00938	0.00938	CcSEcCtD
Procarbazine—Purpura—Thalidomide—leprosy	0.00871	0.00871	CcSEcCtD
Procarbazine—Cough—Dapsone—leprosy	0.00861	0.00861	CcSEcCtD
Procarbazine—Lethargy—Thalidomide—leprosy	0.00856	0.00856	CcSEcCtD
Procarbazine—Diplopia—Thalidomide—leprosy	0.00839	0.00839	CcSEcCtD
Procarbazine—Ataxia—Thalidomide—leprosy	0.00789	0.00789	CcSEcCtD
Procarbazine—Tachycardia—Dapsone—leprosy	0.00786	0.00786	CcSEcCtD
Procarbazine—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00756	0.00756	CcSEcCtD
Procarbazine—Insomnia—Dapsone—leprosy	0.00729	0.00729	CcSEcCtD
Procarbazine—Dysphagia—Thalidomide—leprosy	0.00725	0.00725	CcSEcCtD
Procarbazine—Eosinophilia—Thalidomide—leprosy	0.00718	0.00718	CcSEcCtD
Procarbazine—Pancreatitis—Thalidomide—leprosy	0.00711	0.00711	CcSEcCtD
Procarbazine—Angina pectoris—Thalidomide—leprosy	0.00706	0.00706	CcSEcCtD
Procarbazine—Pancytopenia—Thalidomide—leprosy	0.00689	0.00689	CcSEcCtD
Procarbazine—Pollakiuria—Thalidomide—leprosy	0.0067	0.0067	CcSEcCtD
Procarbazine—Photosensitivity reaction—Thalidomide—leprosy	0.00662	0.00662	CcSEcCtD
Procarbazine—Gastrointestinal pain—Dapsone—leprosy	0.00659	0.00659	CcSEcCtD
Procarbazine—Pneumonia—Thalidomide—leprosy	0.0065	0.0065	CcSEcCtD
Procarbazine—Drowsiness—Thalidomide—leprosy	0.00647	0.00647	CcSEcCtD
Procarbazine—Abdominal pain—Dapsone—leprosy	0.00637	0.00637	CcSEcCtD
Procarbazine—Body temperature increased—Dapsone—leprosy	0.00637	0.00637	CcSEcCtD
Procarbazine—Neuropathy peripheral—Thalidomide—leprosy	0.00634	0.00634	CcSEcCtD
Procarbazine—Stomatitis—Thalidomide—leprosy	0.0063	0.0063	CcSEcCtD
Procarbazine—Sweating—Thalidomide—leprosy	0.0062	0.0062	CcSEcCtD
Procarbazine—Haematuria—Thalidomide—leprosy	0.00617	0.00617	CcSEcCtD
Procarbazine—Epistaxis—Thalidomide—leprosy	0.0061	0.0061	CcSEcCtD
Procarbazine—Chills—Thalidomide—leprosy	0.00521	0.00521	CcSEcCtD
Procarbazine—Arrhythmia—Thalidomide—leprosy	0.00519	0.00519	CcSEcCtD
Procarbazine—Alopecia—Thalidomide—leprosy	0.00513	0.00513	CcSEcCtD
Procarbazine—Vomiting—Dapsone—leprosy	0.00512	0.00512	CcSEcCtD
Procarbazine—Headache—Dapsone—leprosy	0.00505	0.00505	CcSEcCtD
Procarbazine—Tension—Thalidomide—leprosy	0.00496	0.00496	CcSEcCtD
Procarbazine—Nervousness—Thalidomide—leprosy	0.00491	0.00491	CcSEcCtD
Procarbazine—Nausea—Dapsone—leprosy	0.00479	0.00479	CcSEcCtD
Procarbazine—Tremor—Thalidomide—leprosy	0.00473	0.00473	CcSEcCtD
Procarbazine—Anaemia—Thalidomide—leprosy	0.00467	0.00467	CcSEcCtD
Procarbazine—Syncope—Thalidomide—leprosy	0.00453	0.00453	CcSEcCtD
Procarbazine—Leukopenia—Thalidomide—leprosy	0.00452	0.00452	CcSEcCtD
Procarbazine—Loss of consciousness—Thalidomide—leprosy	0.00444	0.00444	CcSEcCtD
Procarbazine—Cough—Thalidomide—leprosy	0.00441	0.00441	CcSEcCtD
Procarbazine—Convulsion—Thalidomide—leprosy	0.00438	0.00438	CcSEcCtD
Procarbazine—Hypertension—Thalidomide—leprosy	0.00436	0.00436	CcSEcCtD
Procarbazine—Arthralgia—Thalidomide—leprosy	0.0043	0.0043	CcSEcCtD
Procarbazine—Myalgia—Thalidomide—leprosy	0.0043	0.0043	CcSEcCtD
Procarbazine—Anxiety—Thalidomide—leprosy	0.00429	0.00429	CcSEcCtD
Procarbazine—Dry mouth—Thalidomide—leprosy	0.00421	0.00421	CcSEcCtD
Procarbazine—Confusional state—Thalidomide—leprosy	0.00416	0.00416	CcSEcCtD
Procarbazine—Oedema—Thalidomide—leprosy	0.00412	0.00412	CcSEcCtD
Procarbazine—Infection—Thalidomide—leprosy	0.0041	0.0041	CcSEcCtD
Procarbazine—Shock—Thalidomide—leprosy	0.00406	0.00406	CcSEcCtD
Procarbazine—Thrombocytopenia—Thalidomide—leprosy	0.00404	0.00404	CcSEcCtD
Procarbazine—Tachycardia—Thalidomide—leprosy	0.00403	0.00403	CcSEcCtD
Procarbazine—Hyperhidrosis—Thalidomide—leprosy	0.00399	0.00399	CcSEcCtD
Procarbazine—Anorexia—Thalidomide—leprosy	0.00393	0.00393	CcSEcCtD
Procarbazine—Hypotension—Thalidomide—leprosy	0.00385	0.00385	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Thalidomide—leprosy	0.00376	0.00376	CcSEcCtD
Procarbazine—Insomnia—Thalidomide—leprosy	0.00373	0.00373	CcSEcCtD
Procarbazine—Paraesthesia—Thalidomide—leprosy	0.0037	0.0037	CcSEcCtD
Procarbazine—Somnolence—Thalidomide—leprosy	0.00367	0.00367	CcSEcCtD
Procarbazine—Decreased appetite—Thalidomide—leprosy	0.00359	0.00359	CcSEcCtD
Procarbazine—Fatigue—Thalidomide—leprosy	0.00356	0.00356	CcSEcCtD
Procarbazine—Constipation—Thalidomide—leprosy	0.00353	0.00353	CcSEcCtD
Procarbazine—Pain—Thalidomide—leprosy	0.00353	0.00353	CcSEcCtD
Procarbazine—Feeling abnormal—Thalidomide—leprosy	0.0034	0.0034	CcSEcCtD
Procarbazine—Gastrointestinal pain—Thalidomide—leprosy	0.00337	0.00337	CcSEcCtD
Procarbazine—Urticaria—Thalidomide—leprosy	0.00328	0.00328	CcSEcCtD
Procarbazine—Body temperature increased—Thalidomide—leprosy	0.00326	0.00326	CcSEcCtD
Procarbazine—Abdominal pain—Thalidomide—leprosy	0.00326	0.00326	CcSEcCtD
Procarbazine—Hypersensitivity—Thalidomide—leprosy	0.00304	0.00304	CcSEcCtD
Procarbazine—Asthenia—Thalidomide—leprosy	0.00296	0.00296	CcSEcCtD
Procarbazine—Pruritus—Thalidomide—leprosy	0.00292	0.00292	CcSEcCtD
Procarbazine—Diarrhoea—Thalidomide—leprosy	0.00282	0.00282	CcSEcCtD
Procarbazine—Dizziness—Thalidomide—leprosy	0.00273	0.00273	CcSEcCtD
Procarbazine—Vomiting—Thalidomide—leprosy	0.00262	0.00262	CcSEcCtD
Procarbazine—Rash—Thalidomide—leprosy	0.0026	0.0026	CcSEcCtD
Procarbazine—Dermatitis—Thalidomide—leprosy	0.0026	0.0026	CcSEcCtD
Procarbazine—Headache—Thalidomide—leprosy	0.00258	0.00258	CcSEcCtD
Procarbazine—Nausea—Thalidomide—leprosy	0.00245	0.00245	CcSEcCtD
